Reviewed,
UniProtKB/Swiss-Prot Q06518 (NOS2_RAT)
Last modified
November 25, 2008.
Version 100.
History...
Clusters with 100%,
90%,
50% identity |
Documents (1) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Nitric oxide synthase, inducible EC=1.14.13.39 Alternative name(s): Inducible NO synthase Short name=Inducible NOS Short name=iNOS NOS type II | ||
| Gene names |
| ||
| Organism | Rattus norvegicus (Rat) | ||
| Taxonomic identifier | 10116 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 1147 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. |
| Catalytic activity | L-arginine + n NADPH + m O(2) = citrulline + nitric oxide + n NADP(+). |
| Cofactor | Heme group. Binds 1 FAD. Binds 1 FMN. Metrahydrobiopterin (BH4). May stabilize the dimeric form of the enzyme. |
| Enzyme regulation | Not stimulated by calcium/calmodulin. Aspirin inhibits expression and function of this enzyme and effects may be exerted at the level of translational/post-translational modification and directly on the catalytic activity By similarity. |
| Subunit structure | Homodimer. Binds SLC9A3R1 By similarity. |
| Tissue specificity | In normal kidney, expressed primarily in the medullary thick ascending limb, with minor amounts in the medullary collecting duct and vasa recta bundle. |
| Induction | By interferon gamma and lipopolysaccharides (LPS). |
| Sequence similarities | Belongs to the NOS family. Contains 1 FAD-binding FR-type domain. Contains 1 flavodoxin-like domain. |
| Caution | Ref.9 sequence was originally thought to originate from human but appears to be from rat. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1147 | 1147 | Nitric oxide synthase, inducible | PRO_0000170937 | |||||
Regions | |||||||||
| Domain | 536 – 674 | 139 | Flavodoxin-like | ||||||
| Domain | 727 – 967 | 241 | FAD-binding FR-type | ||||||
| Nucleotide binding | 620 – 651 | 32 | FMN By similarity | ||||||
| Nucleotide binding | 764 – 775 | 12 | FAD By similarity | ||||||
| Nucleotide binding | 900 – 910 | 11 | FAD By similarity | ||||||
| Nucleotide binding | 975 – 993 | 19 | NADP By similarity | ||||||
| Nucleotide binding | 1073 – 1088 | 16 | NADP By similarity | ||||||
| Region | 506 – 526 | 21 | Calmodulin-binding Potential | ||||||
Sites | |||||||||
| Metal binding | 107 | 1 | Zinc By similarity | ||||||
| Metal binding | 112 | 1 | Zinc By similarity | ||||||
| Metal binding | 197 | 1 | Iron (heme axial ligand) By similarity | ||||||
Experimental info | |||||||||
| Sequence conflict | 10 | 1 | R → K in BAA07994. Ref.7 | ||||||
| Sequence conflict | 72 | 1 | H → Y in BAA03138. Ref.1 | ||||||
| Sequence conflict | 107 | 1 | C → R in AAC13747. Ref.3 | ||||||
| Sequence conflict | 128 | 1 | D → V in BAA12035. Ref.8 | ||||||
| Sequence conflict | 130 | 1 | P → H in AAC13747. Ref.3 | ||||||
| Sequence conflict | 171 | 1 | E → G in BAA12035. Ref.8 | ||||||
| Sequence conflict | 195 | 1 | P → S in BAA12035. Ref.8 | ||||||
| Sequence conflict | 248 | 1 | S → N in AAC83553. Ref.9 | ||||||
| Sequence conflict | 248 | 1 | S → T Ref.3 Ref.5 | ||||||
| Sequence conflict | 264 | 1 | Y → I in AAC13747. Ref.3 | ||||||
| Sequence conflict | 271 | 1 | D → A in AAC83554. Ref.9 | ||||||
| Sequence conflict | 277 | 1 | D → E in AAC13747. Ref.3 | ||||||
| Sequence conflict | 348 | 1 | A → P in BAA03138. Ref.1 | ||||||
| Sequence conflict | 349 | 1 | V → A in CAA54208. Ref.6 | ||||||
| Sequence conflict | 380 | 1 | F → L in AAC83553 and AAC83554. Ref.2 Ref.7 Ref.8 Ref.9 | ||||||
| Sequence conflict | 395 | 1 | R → S in BAA02090. Ref.4 | ||||||
| Sequence conflict | 399 | 1 | E → G in AAC83553. Ref.9 | ||||||
| Sequence conflict | 412 | 1 | V → A in AAC13747. Ref.3 | ||||||
| Sequence conflict | 477 | 1 | M → I Ref.13 | ||||||
| Sequence conflict | 513 | 1 | T → R in AAB18620. Ref.11 | ||||||
| Sequence conflict | 515 | 1 | L → W in AAB31028. Ref.12 | ||||||
| Sequence conflict | 545 | 1 | G → R in AAB31028. Ref.12 | ||||||
| Sequence conflict | 551 | 1 | A → R in AAB18620. Ref.11 | ||||||
| Sequence conflict | 556 | 1 | A → S in AAB31028. Ref.12 | ||||||
| Sequence conflict | 559 | 1 | S → T in AAC83553 and AAC83554. Ref.9 | ||||||
| Sequence conflict | 564 | 1 | T → N in AAB31028. Ref.12 | ||||||
| Sequence conflict | 570 | 1 | E → D in AAB31028. Ref.12 | ||||||
| Sequence conflict | 583 | 1 | L → P Ref.5 Ref.10 | ||||||
| Sequence conflict | 591 | 1 | G → A in AAB31028. Ref.12 | ||||||
| Sequence conflict | 591 | 1 | G → V Ref.1 Ref.6 | ||||||
| Sequence conflict | 619 | 1 | A → R in AAA85861. Ref.2 | ||||||
| Sequence conflict | 640 | 1 | Q → P in AAC83553. Ref.9 | ||||||
| Sequence conflict | 664 | 1 | D → G in AAB18620. Ref.11 | ||||||
| Sequence conflict | 679 – 680 | 2 | ET → VP in BAA03138. Ref.1 | ||||||
| Sequence conflict | 690 | 1 | Q → P in AAB18620. Ref.11 | ||||||
| Sequence conflict | 711 | 1 | S → N in AAB18620. Ref.11 | ||||||
| Sequence conflict | 714 – 715 | 2 | SL → TR in AAB18620. Ref.11 | ||||||
| Sequence conflict | 714 | 1 | S → P in AAC83553 and AAC83554. Ref.2 Ref.7 Ref.8 Ref.9 | ||||||
| Sequence conflict | 714 | 1 | S → P in AAC16401. Ref.10 | ||||||
| Sequence conflict | 719 | 1 | K → R in AAB18620. Ref.11 | ||||||
| Sequence conflict | 721 | 1 | L → P Ref.6 | ||||||
| Sequence conflict | 722 | 1 | S → R Ref.1 Ref.6 Ref.11 | ||||||
| Sequence conflict | 724 – 726 | 3 | IHA → FLN Ref.11 | ||||||
| Sequence conflict | 730 | 1 | F → I in AAB18620. Ref.11 | ||||||
| Sequence conflict | 731 | 1 | T → A in AAC83553. Ref.9 | ||||||
| Sequence conflict | 740 | 1 | L → P in CAA54208. Ref.6 | ||||||
| Sequence conflict | 779 | 1 | A → G in AAC13747. Ref.3 | ||||||
| Sequence conflict | 834 | 1 | P → S in BAA12035. Ref.8 | ||||||
| Sequence conflict | 844 | 1 | A → G in BAA03138. Ref.1 | ||||||
| Sequence conflict | 895 | 1 | S → L in BAA02090. Ref.4 | ||||||
| Sequence conflict | 911 | 1 | Q → L in AAC13747. Ref.3 | ||||||
| Sequence conflict | 925 | 1 | V → D in BAA12035. Ref.8 | ||||||
| Sequence conflict | 937 | 1 | H → N in AAC83554. Ref.9 | ||||||
| Sequence conflict | 999 | 1 | H → R in AAC83553 and AAC83554. Ref.2 Ref.7 Ref.9 | ||||||
| Sequence conflict | 1008 – 1009 | 2 | TL → NF in AAC83554. Ref.9 | ||||||
| Sequence conflict | 1016 | 1 | P → R Ref.5 | ||||||
| Sequence conflict | 1016 | 1 | P → S Ref.8 | ||||||
| Sequence conflict | 1017 | 1 | E → R Ref.5 Ref.8 | ||||||
| Sequence conflict | 1024 | 1 | E → K in AAC83554. Ref.9 | ||||||
| Sequence conflict | 1076 | 1 | L → I in AAC83553. Ref.9 | ||||||
| Sequence conflict | 1084 | 1 | M → I in CAA54208. Ref.6 | ||||||
| Sequence conflict | 1129 | 1 | F → V in AAC83554. Ref.9 | ||||||
| Sequence conflict | 1133 | 1 | A → V in AAC83553 and AAC83554. Ref.2 Ref.7 Ref.9 | ||||||
| Sequence conflict | 1138 | 1 | T → A in AAC83553 and AAC83554. Ref.2 Ref.7 Ref.9 | ||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells." Nunokawa Y., Ishida N., Tanaka S. Biochem. Biophys. Res. Commun. 191:89-94(1993) [PubMed: 7680561] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Vascular smooth muscle. |
| [2] | "Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans." Karlsen A.E., Andersen H.U., Vissing H., Larsen P.M., Fey S.J., Cuartero B.G., Madsen O.D., Petersen J.S., Mortensen S.B., Mandrup-Poulsen T., Boel E., Nerup J. Diabetes 44:753-758(1995) [ |

Clusters with